{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T04:33:00Z","timestamp":1649046780640},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2008,11,14]],"date-time":"2008-11-14T00:00:00Z","timestamp":1226620800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s00393-008-0385-3","type":"journal-article","created":{"date-parts":[[2008,11,14]],"date-time":"2008-11-14T01:05:45Z","timestamp":1226624745000},"page":"677-683","source":"Crossref","is-referenced-by-count":1,"title":["Amyloidosen"],"prefix":"10.1007","volume":"67","author":[{"given":"S.","family":"Ladner-Merz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"M\u00fcller-Ladner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,14]]},"reference":[{"key":"385_CR1","doi-asserted-by":"crossref","unstructured":"Bensson MD (2001) Amyloidosis. In: Seriver CR et al. (eds) The metabolic and molecular bases of inherited diseases, 8th edn. McGraw-Hill, New York, pp 5345\u20135378","DOI":"10.1038\/npg.els.0002146"},{"key":"385_CR2","unstructured":"Cohen AS, Sipe JD (2001) Amyloidosis. In: Rich RR et al. (eds) Clinical immunology, 2nd edn. Mosby Year Book, St. Louis, Chapter 71, pp 1\u20138"},{"key":"385_CR3","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM199709253371306","volume":"337","author":"Falk","year":"2007","unstructured":"Falk RH, Comenzo RL, Skinner M (2007) The systemic amyloidoses. N Engl J Med 337: 898\u2013909","journal-title":"N Engl J Med"},{"key":"385_CR4","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/art.23687","volume":"58","author":"Hoffman","year":"2008","unstructured":"Hoffman HM, Throne ML, Amar NJ et al. (2008) Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. Arthritis Rheum 58: 2443\u20132452","journal-title":"Arthritis Rheum"},{"key":"385_CR5","first-page":"1334","volume":"35","author":"Immonen","year":"2008","unstructured":"Immonen K, Finne P, Hakala M et al. (2008) No improvement in survival of patients with amyloidosis associated with inflammatory rheumatic diseases -- data from the finnish national registry for kidney diseases. J Rheumatol 35: 1334\u20131338","journal-title":"J Rheumatol"},{"key":"385_CR6","first-page":"408","volume":"26","author":"Koivuniemi","year":"2008","unstructured":"Koivuniemi R, Paimela L, Suomalainen R, Leirisalo-Repo M (2008) Amyloidosis as a cause of death in patients with rheumatoid arthritis. Clin Exp Rheumatol 26: 408\u2013413","journal-title":"Clin Exp Rheumatol"},{"key":"385_CR7","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s001080050082","volume":"38","author":"Kr\u00fcger","year":"1997","unstructured":"Kr\u00fcger M, Altland K, Linke RP et al. (1997) Lebertransplantation bei famili\u00e4rer Amyloid-Polyneuropathie. Fallbericht und Literatur\u00fcbersicht. Internist 38: 692\u2013700","journal-title":"Internist"},{"key":"385_CR8","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1517\/14656566.9.12.2175","volume":"9","author":"Manenti","year":"2008","unstructured":"Manenti L, Tansinda P, Vaglio A (2008) Eprodisate in amyloid A amyloidosis: a novel therapeutic approach? Expert Opin Pharmacother 9: 2175\u20132180","journal-title":"Expert Opin Pharmacother"},{"key":"385_CR9","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","volume":"349","author":"Merlini","year":"2003","unstructured":"Merlini G, Berlotti V (2003) Molecular mechanisms of amyloidosis. N Engl J Med 349: 583\u2013596","journal-title":"N Engl J Med"},{"key":"385_CR10","doi-asserted-by":"crossref","unstructured":"Palladini G, Russo P, Lavatelli F et al. (2008) Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomide. Ann Hematol [Epub ahead of print]","DOI":"10.1007\/s00277-008-0600-y"},{"key":"385_CR11","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10067-008-0875-3","volume":"27","author":"Perry","year":"2008","unstructured":"Perry ME, Stirling A, Hunter JA (2008) Effect of etanercept on serum amyloid A protein (SAA) levels in patients with AA amyloidosis complicating inflammatory arthritis. Clin Rheumatol 27: 923\u2013925","journal-title":"Clin Rheumatol"},{"key":"385_CR12","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1517\/14656566.9.12.2117","volume":"9","author":"Pettersson","year":"2008","unstructured":"Pettersson T, Konttinen YT, Maury CP (2008) Treatment strategies for amyloid A amyloidosis. Expert Opin Pharmacother 9: 2117\u20132128","journal-title":"Expert Opin Pharmacother"},{"key":"385_CR13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00428-001-0582-9","volume":"440","author":"R\u00f6cken","year":"2002","unstructured":"R\u00f6cken C, Shakespeare A (2002) Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch 440: 111\u2013122","journal-title":"Virchows Arch"},{"key":"385_CR14","first-page":"2237","volume":"103","author":"Sch\u00f6nland","year":"2006","unstructured":"Sch\u00f6nland SO (2006) Fortschritte in der Diagnostik und Therapie der Amyloidosen. Dtsch \u00c4rztebl 103: 2237\u20132244","journal-title":"Dtsch \u00c4rztebl"},{"key":"385_CR15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-140-2-200401200-00008","volume":"140","author":"Skinner","year":"2004","unstructured":"Skinner M, Sanchorawala V, Seldin DC et al. (2004) High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: An 8-year study. Ann Intern Med 140: 85\u201393","journal-title":"Ann Intern Med"},{"key":"385_CR16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2141.2007.06936.x","volume":"140","author":"Wechalekar","year":"2008","unstructured":"Wechalekar AD, Hawkins PN, Gillmore JD (2008) Perspectives in treatment of AL amyloidosis. Br J Haematol 140: 365\u2013377","journal-title":"Br J Haematol"},{"key":"385_CR17","doi-asserted-by":"crossref","unstructured":"Wechalekar AD, Lachmann HJ, Goodman HJ et al. (2008) AL amyloidosis associated with IgM paraproteinaemia - clinical profile and treatment outcome. Blood [Epub ahead of print]","DOI":"10.1182\/blood-2008-02-138156"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-008-0385-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-008-0385-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-008-0385-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T12:35:57Z","timestamp":1559046957000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-008-0385-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,14]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["385"],"URL":"https:\/\/doi.org\/10.1007\/s00393-008-0385-3","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,14]]}}}